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Abstract 
BACKGROUND: Goal-directed fluid therapy (GDFT) improved patient outcomes in various surgical procedures; 
however, its role during mass brain resection was not well investigated.  
AIM: In this study, we evaluated a simple protocol based on intermittent evaluation of pulse pressure variation for 
guiding fluid therapy during brain tumour resection. 
METHODS: Sixty-one adult patients scheduled for supratentorial brain mass excision were randomized into either 
GDFT group (received intraoperative fluids guided by pulse pressure variation) and control group (received 
standard care). Both groups were compared according to the following: brain relaxation scale (BRS), mean 
arterial pressure, heart rate, urine output, intraoperative fluid intake, postoperative serum lactate, and length of 
hospital stay. 
RESULTS: Demographic data, cardiovascular data (mean arterial pressure and heart rate), and BRS were 
comparable between both groups. GDFT group received more intraoperative fluids {3155 (452) mL vs 2790 (443) 
mL, P = 0.002}, had higher urine output {2019 (449) mL vs 1410 (382) mL, P < 0.001}, and had lower serum 
lactate {0.9 (1) mmol versus 2.5 (1.1) mmol, P = 0.03} compared to control group. 
CONCLUSION: In conclusion, PPV-guided fluid therapy during supratentorial mass excision, increased 
intraoperative fluids, and improved peripheral perfusion without increasing brain swelling.  
 
 
 
 
 
 
Introduction 
 
Neurosurgical operations are characterised by 
major fluid shift, frequent use of diuretics, and 
prolonged operative time. The role of fluid therapy in 
these patients is very critical; hypovolemia might 
decrease cerebral perfusion; while, fluid over-infusion 
might swell the brain. Thus, fluid management in 
these procedures complex and challenging. Evidence 
on the optimum protocol for intraoperative fluid 
management in neurosurgical patients is still lacking. 
Adequate intracranial volume management is 
considered a key factor that would overcome the 
tumour bulk and the surrounding vasogenic oedema 
facilitating surgical access [1]. Thus, a relaxed brain is 
one of the targets of intraoperative fluid management 
during craniotomy [1], [2]. The slack brain would allow 
proper surgical retraction and consequently, reduces 
brain retractor ischemia. Brain relaxation scale (BRS) 
had shown a good correlation with intracranial 
pressure [3]; thus, an increasing interest was paid to 
BRS as a simple surrogate for intracranial pressure 
[1], [2], [4]. 
Goal-directed hemodynamic therapy (GDT) in 
the operating room is a term used to describe the use 
of defined hemodynamic targets to guide intravenous 
fluid and inotropic therapy [5]. Pulse pressure 
variation (PPV) is one of the robust dynamic indices of 
fluid responsiveness which is based on heart-lung 
interactions [6]. GDT had been frequently investigated 
in the operating room in high-risk patients especially in 
major surgery [7], [8], [9]. However, the impact of GDT 
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on patient outcomes, especially BRS, is not well 
evaluated in brain surgery. In this study, we evaluated 
PPV-guided fluid management compared to standard 
fluid management in patients undergoing 
supratentorial mass excision. We hypothesised that in 
these procedures, GDT might restrict intraoperative 
fluid volume, improve brain relaxation, and provide 
stable patient hemodynamics. 
 
 
Methods 
 
A randomised, controlled study was 
conducted in Cairo University hospitals between 
March 2017 and January 2018, after being approved 
by the research ethics board (MD-4-2016). Written 
informed consent was obtained from all subjects who 
participated in this trial. The study was registered 
before patient enrolment at clinicaltrials.gov registry 
system (NCT03033706, principal investigator: Ahmed 
Hasanin, date of registration: January 27
th
, 2017). 
Sixty-one patients scheduled for 
supratentorial mass excision were enrolled in the 
study. Patients less than 18 years old, patients with 
arrhythmias, pulmonary hypertension, impaired 
cardiac contractility, impaired liver or kidney function, 
and patients with body mass index above 40 were 
excluded. Randomisation was achieved using a 
computer-generated sequence. Opaque envelopes 
were used to assign patients in one of the two study 
groups. 
 
Management of anaesthesia 
Patients were pre-medicated with ranitidine 
(50 mg) and ondansetron (4 mg). Anaesthesia was 
induced using Propofol 2 mg/kg, atracurium 0.5 
mg/Kg, and fentanyl 2 µg/Kg, and maintained using 
isoflurane (1-1.5%) and atracurium 0.5 mg/Kg/h. After 
induction of anaesthesia, arterial and right internal 
jugular central venous catheters were inserted. The 
endotracheal tube was inserted, and mechanical 
ventilation was adjusted at a tidal volume of 8 mL/Kg, 
no PEEP, respiratory rate was adapted to maintain 
end-tidal CO2 between (30-35 mmHg). Patients’ 
monitors included: continuous electrocardiograph, 
continuous invasive arterial pressure monitor, pulse 
oximetry, end-tidal CO2 monitor, central venous 
pressure (CVP), and non-invasive blood pressure 
monitor. Mannitol (0.5 gm/Kg) was administered 
shortly after induction. Phenytoin (15 mg/Kg) was 
administered for loading if the patient was not 
previously loaded. Maintenance bolus of phenytoin (5 
mg/Kg) was administered for previously loaded 
patients. Additional doses of fentanyl (50 µg/dose) 
were titrated with skin incision, and bur-hole keep 
means arterial pressure (MAP) and heart rate within 
25% of the baseline reading. By the end of the 
operation; isoflurane was discontinued, and the 
residual neuromuscular blocking agent was reversed 
by neostigmine 0.05 mg/Kg and atropine 0.02 mg/Kg. 
Patients were extubated and admitted to the surgical 
intensive care unit. 
 
Fluid therapy 
All patients received a fluid bolus of 5 ml/kg 
Tetrastarch (Voluven: Hydroxyethyl starch 130/0.4 in 
isotonic sodium chloride solution manufactured by 
Fresenius Kabi Germany) after induction of 
anaesthesia, then fluid management was as follows: 
Control group: in this group, patients received 
standard fluid management of 4 ml/Kg/hr ringer 
solution. If MAP decreased by 20% without obvious 
bleeding, the patient received a rescue fluid bolus of 3 
mL/Kg Ringer solution over 5 minutes if CVP was 
lower than 4 mmHg, and received ephedrine bolus of 
9 mg if CVP was higher than 4 mmHg.  
GDT group: in this group, patients received a 
restricted fluid protocol of 1 ml/Kg/hr with concomitant 
PPV monitoring. The fluid bolus of 3 ml/Kg of ringer 
solution was administrated whenever PPV was higher 
than 13%. If the MAP decreased by 20% without 
obvious bleeding, the patient received ephedrine 
bolus of 9 mg. 
PPV was assessed using invasive blood 
pressure monitor (GE solar 8000M/I monitor) every 15 
minutes. PPV was calculated using the following 
equation [6]: 
       
             
             
 
     
Maximal PP (PPmax) and minimal PP (PPmin) 
were obtained from the same respiratory cycle. PPV 
was calculated as the average of measurements 
obtained over three consecutive respiratory cycles. 
In both groups, urine output was calculated 
and replaced using Ringer’s solution. Blood loss was 
replaced by tetrastarch solution in the ratio of 1:1. 
Packed RBCs were transfused if blood haemoglobin 
was less than 7 g/dL. 
 
Outcomes 
Our primary outcome was brain Relaxation 
scale (BRS). BRS was assessed by the neurosurgeon 
at 3-time intervals; with dural opening, after two hours, 
and before dural closure. A 4-point scale [2] was 
performed as follows: grade 1, perfectly relaxed; 
grade 2, satisfactorily relaxed; grade 3, firm brain; 
grade 4, bulging brain. The surgeon was blinded to 
the study group. The end-tidal CO2 was tightly 
controlled at 30-35 mmHg during the assessment of 
BRS. 
In addition to demographic data (age, gender, 
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weight, ASA class, incidence of disturbed conscious 
level “defined as Glasgow Coma Scale below 15”, and 
incidence of preoperative neurological deficit “defined 
as as upper and/or lower limb weaknesses in 
contralateral side of the tumor; the presence of 
dysphasia, visual field defects were considered as 
neurological deficits as well.”), other outcomes 
included: Intraoperative fluid requirements, patient 
position during the operation, arterial-jugular oxygen 
saturation difference, arterial-Jugular lactate 
difference, urine output, vital signs (heart rate and 
MAP) arterial blood gases, intraoperative ephedrine 
consumption, postoperative electrolytes (Na, K, Mg, 
and Ca), postoperative serum lactate, postoperative 
24-hour urine output, postoperative hemoglobin, and 
length of hospital stay. 
 
Statistical analysis and sample size 
 calculation 
Our primary outcome was brain relaxation 
scale. A previous study [2] had assumed that a 
difference in mean BRS of 1 ± 1 is a clinically 
significant difference. We used a more conservative 
assumption to detect the same mean difference in 
BRS with a higher study power (95%). A minimum 
number of 26 patients per group was calculated Using 
MedCalc Software version 14.10.2 (MedCalc Sofware 
bvba, Ostend, Belgium), the minimum calculated 
number of participants to have a study power of 95% 
and an alpha error of 0.05 was 27 patients per group.  
Statistical package for social science (SPSS) 
software, version 15 for Microsoft Windows (SPSS 
inc., Chicago, iL, USA) was used for data analysis. 
Continuous data were checked for normality using the 
Shapiro-Wilk test and was presented as mean 
(standard deviation) or median (interquartile range) as 
appropriate. Continuous data were analysed using 
unpaired t-test or Mann Whitney test as appropriate. 
Categorical data were presented as frequency (%) 
and analysed by chi-squared test. Repeated 
measures were analysed using analysis of variance 
(ANOVA) for repeated measures with post-hoc 
pairwise comparisons using the Bonferroni test. A P 
value less than 0.05 was considered statistically 
significant. 
 
 
Results 
 
Seventy-five patients were screened for 
eligibility. Fourteen patients were excluded (10 
patients were excluded from meeting one of the 
exclusion criteria, and 4 patients declined to 
participate in the study). Sixty-one patients were 
available for final analysis (Figure 1). 
 
Figure 1: Consort chart showing patient recruitment; GDT: Goal-
directed fluid therapy 
 
 Both groups were comparable according to 
demographic data and baseline characteristics (Table 
1).  
Table 1: Demographic data and patient characteristics. Data 
are presented as mean (standard deviation), and frequency (%) 
 Control group (n = 30) GDT group (n = 31) P value 
Age (years) 39 (13) 41 (12) 0.43 
Weight (Kg) 77 (12) 76 (10) 0.85 
Male gender 12 (40%) 16 (52) 0.4 
ASA class (I/II) 20/10 19/12 0.87 
DCL 1 (3%) 2 (7%) 1 
Increased ICP 2 (7%) 4 (13%) 0.7 
Neurological deficit 3 (10%) 2 (7%) 0.7 
Convulsions 3 (10%) 2 (7%) 0.6 
Tumour type (%) 
Meningioma 
Glioma 
Intraventricular tumour 
Craniopharyngioma 
Other lesions 
 
50% 
25% 
8% 
8% 
9% 
 
46% 
18% 
14% 
5% 
17% 
0.93 
Largest tumour diameter 5.9 (3) 5.4 (1.7) 0.42 
Surgical duration (hours) 5.3 (1.1) 5.5 (0.9) 0.48 
Baseline heart rate (bpm) 82 (7) 83 (7) 0.56 
Baseline MAP (mmHg) 88 (9) 92 (10) 0.12 
ASA: American society of anesthesiology classification; DCL: disturbed conscious level; 
ICP: intra-cranial pressure; MAP: mean arterial pressure. 
 
All patients were operated in a supine, head-
up position. The GDT group received a greater 
number of fluid boluses and had higher total fluid 
consumption compared to the control group (Table 2).  
Table 2: Fluid management and urine output. Data are 
presented as mean (standard deviation), and median (quartiles) 
 Control group (n = 30) GDT group (n = 31) P value 
Infused fluids (mL) 
Total 
Crystalloids 
Colloids 
 
 
2790 (443) 
2408 (418) 
383 (61) 
 
3155 (452) * 
2775 (423) * 
380 (51) 
 
0.002 
0.01 
0.85 
Urine output (mL) 1410 (382) 2019 (449) * < 0.001 
Blood loss (mL) 897 (430) 887 (377) 0.93 
Blood transfusion (mL) 885 (363) 773 (334) 0.45 
Number of fluid boluses 2 (1.2) 5 (5.6) * < 0.001 
Number of vasopressor 
boluses 
0 (0.1) 0 (0.1) 0.093 
*denotes statistical significance compared to the control group. 
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Higher urine output and lower postoperative 
serum lactate were reported in the GDT group 
compared to the control group (Table 2, and 4).  
Table 3: Brain relaxation scores. Data are presented as mean 
(standard deviation), and median (quartiles) 
 Control group (n = 30) GDT group (n = 31) P value 
BRS-1 
Mean (SD) 
Median (quartiles) 
 
1.8 (0.7) 
2 (1.2) 
 
1.54 (0.7) 
1 (1.2) 
0.15 
BRS-2 
Mean (SD) 
Median (quartiles) 
 
1.9 (0.6) 
2 (2.2) 
 
1.8 (0.4) 
2 (2,2) 
0.66 
BRS-3 
Mean (SD) 
Median (quartiles) 
 
1.7 (0.4) 
2 (1.2) 
 
1.58 (0.5) 
2 (1.2) 
0.34 
BRS: brain relaxation score, SD: standard deviation. 
 
No significant differences were reported 
between both groups in BRS (Table 3), intraoperative 
mean arterial pressure (Figure 2), nor heart rate.  
 
Figure 2: Mean arterial pressure; Markers are means, error bars are 
standard deviations; * denotes statistical significance compared to 
the baseline reading within the control group. † Denotes statistical 
significance compared to the baseline reading within the GDT 
group; GDT: Goal-directed fluid therapy 
 
Postoperative laboratory investigations 
(haemoglobin, coagulation profile, and electrolytes), 
postoperative intensive care unit stay and 
postoperative hospital stay were comparable between 
both groups (Table 4). 
Table 4: Postoperative data. Data are presented as mean 
(standard deviation), and median (quartiles) 
 Control group (n = 30) GDT group (n = 31) P value 
PH 7.38 (0.09) 7.39 (0.06) 0.56 
Lactate (mmol/L) 2.5 (1.1) 0.9 (1) * 0.03 
ScVo2 (%) 75 (6.3) 74 (5.2) 0.69 
Arterio-jugular Spo2 
difference (%) 
23.6 (7.6) 25.5 (5.1) 0.26 
Arterio-jugular lactate 
difference (mmol/L) 
0.5 (0.2,0.6) 0.4 (0.2,0.5) 0.25 
Postoperative urine output 
(mL) 
1152 (261) 1277 (269) 0.07 
ICU stay (days) 2.1 (1.3) 2.1 (1.2) 0.93 
Hospital stay (days) 5.7 (1.5) 5.2 (1.3) 0.13 
Scvo2: central venous oxygen saturation; Spo2: arterial oxygen saturation; * denotes 
statistical significance compared to the control group. 
 
 
Discussion 
 
We found that the GDT group received more 
fluids compared to the control group without impacting 
BRS. Postoperative serum lactate was lower in the 
GDT denoting better peripheral organ perfusion 
compared to the control group. Patients undergoing 
craniotomy receive brain dehydrating measures; thus, 
they are vulnerable to intravascular volume depletion. 
Using PPV as a marker of volume status allowed 
accurate and early detection of hypovolemia; thus, 
more fluids were infused in the GDT group compared 
to the standard therapy group. The relatively better 
peripheral perfusion in the GDT group is most 
probably due to adequate and early restoration of 
intravascular volume using an accurate and reliable 
hemodynamic target before the occurrence of 
hypotension. The use of CVP as a measure for fluid 
responsiveness is declining; however, it is still 
conventionally used by many physicians [10], [11]. 
PPV had been reported to be a more accurate index 
for fluid responsiveness especially in mechanically 
ventilated patients [6]. 
In our study, we tried to answer two 
questions: 1- Would the PPV-guided therapy impact 
BRS? 2- Would PPV-guided therapy improve the 
hemodynamic profile and peripheral perfusion? We 
hypothesised that using GDT might avoid 
unnecessary excessive fluids; thus, we designed our 
study to provide a baseline restrictive fluid infusion 
rate (1 mL/Kg/hour) in the GDFT group with additional 
fluid boluses according to the PPV values. 
Surprisingly, the GDT group required more fluids than 
the control group due to the higher number of fluid 
boluses. 
In our patients, better peripheral perfusion 
was reported in the GDT group. This was represented 
by the lower postoperative serum lactate level in 
addition to higher fluid volume and a smaller number 
of vasopressor boluses in the GDT group. Serum 
lactate is an important marker of tissue perfusion [12]. 
Postoperative serum lactate is a commonly used 
marker of peripheral perfusion during craniotomy [2], 
[4], [13], [14]. Elevated serum lactate level is usually 
associated with poor outcomes [14], especially in 
patients undergoing craniotomy [16]. Our results are 
in line with two recent randomised controlled studies. 
In the first study, Wu et al., [13] had recently 
compared two-stroke volume variation-based fluid 
protocols in neurosurgical procedures. Wu et al. had 
reported that the more liberal fluid protocol (targeting 
lower stroke volume variation) was associated with 
lower postoperative serum lactate compared to the 
restrictive protocol (targeting higher stroke volume 
variation). In the second study, Sundaram et al. 
compared PPV-directed therapy to CVP-guided 
therapy and found that the patients in PPV-guided 
therapy group received more fluids and had more 
stable hemodynamic profile compared to the CVP-
guided group [17]. Our study showed similar results to 
the two mentioned studies concerning the higher fluid 
requirements and the better peripheral perfusion. 
Furthermore, we had also reported that the higher 
fluid requirements in the GDT group were not 
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associated with brain swelling.  
In a randomised controlled study, Luo et al. 
had investigated stroke volume variation-guided fluid 
therapy in brain surgeries [18]. Unlike our study, Luo 
et al. had given less intraoperative fluids in their study 
group compared to the control group. Two differences 
between our study and Luo study might account to the 
different findings: 1-Their fluid protocol in the control 
group was not well clarified. 2-They had used higher 
baseline fluid infusion rate (3 mL/Kg/hour) in their 
study group compared to our baseline infusion rate (1 
mL/Kg/hour).  
Two previous studies had evaluated the 
impact of GDT on BRS; however, both studies aimed 
to compare colloid and crystalloid solutions in 
neurosurgical patients [4], [19]; thus, they used GDT 
in both study groups and did not compare GDT to 
standard care. Our study is the first to evaluate the 
impact of GDT, compared to standard care, on BRS in 
addition to intraoperative fluid requirements and 
peripheral perfusion.  
Usually, the neurosurgical patient is kept as 
dry as possible. However, to which extent should we 
restrict fluids? This question has not been adequately 
answered. The relationship between perioperative 
fluid administration and patient outcome is U-shaped. 
Under-transfusion results in cerebral, myocardial, and 
renal ischemia; while, fluid overload leads to lung 
congestion, brain oedema, and delayed wound 
healing [20]. Neurosurgical procedures are 
characterised by difficult assessment of blood loss 
under the drapes especially in the presence of 
irrigating fluids. The frequent use of diuretics makes 
urine output unreliable index for evaluation of volume 
status. Thus, it is necessary to use reliable 
parameters for guiding fluid management. It is highly 
believed that fluid administration should target clear 
hemodynamic variables rather than targeting 
traditional, fixed infusion rate. We chose PPV as a 
target for fluid management in our patients as it is a 
simple, accurate dynamic method of fluid 
responsiveness in mechanically ventilated patients [6]. 
Based on our findings, we found that using PPV for 
guiding fluid management in neurosurgical patients is 
feasible and has promising results. Using PPV would 
be also beneficial for patients whom anesthesiologists 
do not prefer central venous line insertion. Our 
findings might draw attention to the under-determined 
fluid needs during mass brain resection.  
One of the limitations for implementing GDT 
in the operating room is the need for either 
complicated algorithms or sophisticated equipment. 
Introduction of simple protocols for GDT would enable 
wider application in different settings. Our study has 
the advantage of the use of a simple GDT protocol 
based on optimisation of PPV which needs only an 
arterial line. Most of other GDT protocols are based 
on either complicated algorithms or sophisticated 
equipment.  
Our study had some limitations: 1-It is a single 
centre study. 2-All our operations were elective 
operations. 3-We had a low incidence of disturbed 
conscious level and increased intracranial pressure; 
thus, extrapolation of our findings in these groups of 
patients' needs more research.  
In conclusion, guiding fluid therapy using 
manual, intermittently calculated PPV during 
supratentorial mass excision increased intraoperative 
fluid administration and improved peripheral perfusion 
without impacting brain relaxation. More research is 
warranted to reach the optimum strategy and the best 
cut-off targets. 
 
 
Ethical approval and consent to 
participate 
 
Ethical approval from Cairo university 
hospitals research committee was obtained (MD-4-
2016). Written informed consents were obtained from 
participants before inclusion. 
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